Tyra Biosciences Statistics Share Statistics Tyra Biosciences has 53.23M
shares outstanding. The number of shares has increased by 0.84%
in one year.
Shares Outstanding 53.23M Shares Change (YoY) 0.84% Shares Change (QoQ) 4.78% Owned by Institutions (%) 81.83% Shares Floating 33.78M Failed to Deliver (FTD) Shares 757 FTD / Avg. Volume 0.26%
Short Selling Information The latest short interest is 5.75M, so 10.78% of the outstanding
shares have been sold short.
Short Interest 5.75M Short % of Shares Out 10.78% Short % of Float 15.79% Short Ratio (days to cover) 32.89
Valuation Ratios The PE ratio is -9.2 and the forward
PE ratio is -5.37.
Tyra Biosciences's PEG ratio is
1.35.
PE Ratio -9.2 Forward PE -5.37 PS Ratio 0 Forward PS 979.6 PB Ratio 2.32 P/FCF Ratio -11.29 PEG Ratio 1.35
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tyra Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 23.81,
with a Debt / Equity ratio of 0.02.
Current Ratio 23.81 Quick Ratio 23.81 Debt / Equity 0.02 Debt / EBITDA -0.07 Debt / FCF -0.09 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.44M Employee Count 60 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -38.56% in the
last 52 weeks. The beta is 1.1, so Tyra Biosciences's
price volatility has been higher than the market average.
Beta 1.1 52-Week Price Change -38.56% 50-Day Moving Average 10.88 200-Day Moving Average 11.76 Relative Strength Index (RSI) 62.48 Average Volume (20 Days) 286,529
Income Statement
Revenue n/a Gross Profit -519K Operating Income -104.18M Net Income -86.48M EBITDA -85.96M EBIT -86.48M Earnings Per Share (EPS) -1.51
Full Income Statement Balance Sheet The company has 91.97M in cash and 6.22M in
debt, giving a net cash position of 85.74M.
Cash & Cash Equivalents 91.97M Total Debt 6.22M Net Cash 85.74M Retained Earnings -251.31M Total Assets 321.5M Working Capital 288.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -69.77M
and capital expenditures -664K, giving a free cash flow of -70.44M.
Operating Cash Flow -69.77M Capital Expenditures -664K Free Cash Flow -70.44M FCF Per Share -1.23
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
